Nemolizumab, CAS [[1476039-58-3]]

Produktübersicht

• Artikelname: Nemolizumab, CAS [[1476039-58-3]]
• Artikelnummer: TGM-T76724
• Hersteller Artikelnummer: T76724
• Alternativnummer: TGM-T76724-1MG,TGM-T76724-5MG,TGM-T76724-10MG,TGM-T76724-25MG,TGM-T76724-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: CIM331

Produktbeschreibung

Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1476039-58-3]
• Target-Kategorie: Interleukin